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In Brief Kalousi et al. show that SET is recruited to double-strand breaks to moderate the DNA damage response and inhibit resection and homologous recombination (HR) through increased retention of KAP1 and HP1g on chromatin.
INTRODUCTION
Various types of agents from either exogenous or endogenous sources constantly assault DNA (Ciccia and Elledge, 2010; Hoeijmakers, 2001) . DNA double-strand breaks (DSBs) are together with interstrand cross-links among the less frequent but the most toxic lesions because interaction between DNA ends from different DSBs can produce tumorigenic chromosome translocations (Misteli and Soutoglou, 2009 ). DSBs are repaired by two main pathways: non-homologous end-joining (NHEJ) and homologous recombination (HR) (Goodarzi and Jeggo, 2013) . NHEJ is used by cells to join broken ends by simple re-ligation (Wang and Lees-Miller, 2013) . HR takes advantage of the information encoded by the homologous template of the sister chromatid to repair the DSB in an error-free manner (Krejci et al., 2012) .
DSBs trigger a complex cascade of signaling events known as the DNA damage response (DDR). During the DDR, DNA damage triggers the activation of phosphatidylinositol 3-kinases ATM/DNAPK/ATR (ataxia telangiectasia mutated/DNA-dependent protein kinase/ataxia telangiectasia and Rad3 related) and the activation of cell-cycle checkpoint kinases, which in turn pause the cell cycle until the DNA lesion is repaired (Bartek and Lukas, 2007) .
DNA in the eukaryotic cell is complexed with histone proteins to form chromatin. Therefore, DNA repair generally occurs in the context of highly structured chromatin and, as a result, the cell has evolved mechanisms to open the chromatin structure and facilitate repair (Lemaître and Soutoglou, 2014; Soria et al., 2012) . Emerging evidence suggests that the ability of repair factors to detect DNA lesions is determined by histone modifications around the lesion and involves chromatin-remodeling events (Polo and Jackson, 2011) . The most prominent DNA-damageinduced histone modification in DNA DSB repair (DSBR) is the phosphorylation of the C-terminal tail of H2AX, referred to as gH2AX (Rogakou et al., 1998) . Other chromatin proteins, such as the Kruppel-associated box (KRAB)-associated co-repressor KAP1, are also phosphorylated by ATM in response to DNA DSBs to further facilitate the decondensation of chromatin and allow efficient repair (Goodarzi et al., 2008; Ziv et al., 2006) . Although there is increasing evidence that chromatin alterations are essential for efficient DSBR, the mechanisms underlying these chromatin changes are far from being fully understood.
In this study, we identified the oncoprotein SET as a modulator of the DDR using a small interfering RNA (siRNA)-based screen of chromatin-related proteins. We show that depletion of SET increases DDR and survival in the presence of radiomimetic drugs. On the other hand, SET overexpression impairs DDR, DNA break processing, and consequent repair by HR. SET interacts with the co-repressor KAP1, and its overexpression leads to the sustained retention of KAP1 and HP1 on chromatin. Our results suggest a model in which this retention triggers an inhibition of resection, impairing HR regulation.
RESULTS
The Nuclear Oncogene SET Is a Modulator of DDR in Chromatin Surrounding DSBs To evaluate the impact of high-ordered chromatin structure in DDR and DNA repair in an unbiased way, we performed an siRNA screen using a library with chromatin-related proteins and their interaction partners. We identified the nuclear oncogene SET as a modulator of DDR since downregulation of SET resulted in a significant increase in levels of gH2AX foci remaining at 16 hr following Neocarzinostatin (NCS) treatment. This is similar to the DNA repair defect observed in cells depleted for XRCC4 ( Figure 1A ). Depletion of SET by two different siRNAs validated the phenotype observed in the primary screen (Figure 1B) . The knockdown efficiency was monitored by qRT-PCR and western blot analysis ( Figures S1A and S1B) .
To validate the screen results in another cell type, we performed western blot analysis in control U2OS cells and in cells depleted for SET. We indeed observed higher damage-induced gH2AX levels in cells where SET was downregulated ( Figure 1C) . Interestingly, the level of gH2AX was increased immediately upon DNA damage and was sustained at a higher level until 8 hr later ( Figure 1C ). These results point to two different possibilities. First that depletion of SET results in persistent DNA damage, suggesting a role of SET in facilitating repair of DNA lesions. Another possible explanation is that downregulation of SET results in higher accessibility of H2AX to DDR kinases due to altered chromatin conformation, without affecting the number of unrepaired DNA breaks.
To differentiate between these two different possibilities, we used comet assays to measure the number of DNA lesions in control and SET-depleted cells. We did not observe a significant increase of breaks at any time upon DNA damage in cells lacking SET ( Figure S1C ). These results suggest that depletion of SET is affecting neither the initial number of DNA lesions nor their repair efficiency, as it was observed upon depletion of XRCC4, and point to the second possibility.
To further investigate the role of SET in checkpoint activation, we examined the phosphorylation status of Chk1 and Chk2 in controls cells and SET-depleted cells. Depletion of SET did not considerably alter Chk1 or Chk2 phosphorylation ( Figure 1C) , further strengthening the point that SET depletion does not lead to persistent DNA damage. Interestingly, and consistent with the enhanced DDR, SET-depleted cells exerted slower recovery from the G2/M checkpoint arrest from control cells (Figure S1D) . To further evaluate the involvement of SET in genome integrity, we performed clonogenic survival assays in U2OS cells treated with the radiomimetic drug phleomycin. We observed that SET-depleted cells survive better in the presence of DNA damage than control cells ( Figure 1D ), suggesting that downregulation of SET renders DDR more efficient.
To investigate whether SET has a direct role in DDR, we tested the recruitment of SET fused to GFP in laser-induced breaks. Notably, SET was recruited to lesions instantly upon laser induction ( Figure 1E ). We also tested the recruitment of SET in endonuclease-induced breaks by chromatin immunoprecipitation (ChIP) . We found that SET is clearly recruited in I-SceI breaks, and we monitored the efficiency of break induction by gH2AX ChIP (Figures 1F and S1E ). The observed fluctuations in SET recruitment in the laser microirradiation experiments prompted us to investigate whether the recruitment of SET is cell cycle specific. To this end, we performed ChIP experiments using SET antibody in cells arrested in G1/S or G2, and we observed that the recruitment of SET is more pronounced in cells arrested in G2 ( Figures 1G and S1F) .
All of the above results suggest that SET is recruited to DSBs to regulate DDR activation.
SET Overexpression Impedes DDR and Recruitment of HR Factors at Collapsed Forks and DSBs
The above findings support a potentially deleterious effect of high levels of SET. Indeed, SET is found to be highly overexpressed in a variety of cancers Li et al., 2012) . To assess the impact of SET overexpression in genomic instability, we established a cellular model for SET overexpression in U2OS cells ( Figures S2A-S2C ). We generated U2OS stable cell lines overexpressing SET fused to GFP Figure 1 . The Nuclear Oncogene SET as a Factor Affecting the DDR (A) SET as a major hit of a high-throughput siRNA screen to identify new chromatin-related DDR factors. HeLa cells were transfected with siGFP, siXRCC4, or siSET (pool) in 96-well plates. 72 hr post-transfection cells were treated with 50 ng/ml NCS for 15 min before being released for another 16 hr. Cells were then fixed and immunostained for gH2AX. Levels of gH2AX intensity were measured by an automated microscope. (B) As in (A), the initial screen was validated using two individual siRNAs for SET (siSET-1 and -2). (C) Western blot analysis of U2OS cells transfected with siSCR or siSET for 72 hr before being treated with 50 ng/ml NCS for 15 min and released for different time points is shown. (D) Clonogenic survival of U2OS cells transfected with siSCR or siSET and treated with increasing concentrations of phleomycin. SEM represents the errors from three independent experiments. Statistical significance in all experiments was calculated using the t test (*p < 0.05, **p < 0.01, ***p < 0.001). (E) Laser-induced DNA damage. Live cell imaging was performed after laser irradiation of U2OS cells co-expressing GFP-SET and mRuby2-Ku80 (scale bar represents 10 mm). (GFP-SET). A U2OS stable cell line overexpressing GFP was used as negative control. The level of overexpression of the SET protein was three to four times higher than the endogenous level of SET ( Figure S2C ). GFP-SET displayed nuclear localization similar to the endogenous protein ( Figure S2B ), and the overexpressed fusion protein did not alter the localization or the partition of endogenous SET to chromatin ( Figure S2D ).
To first test whether SET overexpression limits DDR, we evaluated gH2AX induction in GFP and GFP-SET cells upon NCS treatment. Interestingly, although, the DDR mounting in asynchronous SET-overexpressing cells was quite similar to control cells, gH2AX upon SET overexpression was significantly affected in cells arrested in G2 (Figure 2A ). This observation is in line with the enhanced recruitment of SET in DNA lesions occurring in G2 ( Figure 1G) .
To assess the impact of SET overexpression in genomic instability, we performed clonogenic survival assays in U2OS GFP and GFP-SET cells in the presence of different damaging agents. We observed that cells overexpressing SET are mainly sensitive to the replication stress agent camptothecin and not phleomycin (Figures 2B and S2E) . Therefore, our results strengthen the notion that SET overexpression affects the DDR or repair of lesions occurring in S-G2 phase.
In line with these results, cells overexpressing SET, although when not challenged do not demonstrate major changes in cell cycle or proliferation rates ( Figures 2C and S2H ), exerted slower progression through S-G2 phase compared to GFP cells when challenged with phleomycin ( Figure S2F ) and the replication stress agent hydroxyurea (HU) ( Figure 2C ), further suggesting an impairment in sensing or repairing lesions occurring during S phase. To further analyze this phenomenon with a specific S phase marker, we performed BrdU staining after treatment with HU in U2OS cells overexpressing GFP-SET or GFP (Figure S2G) . In agreement with the previous observation, we observed a substantial increase in the proportion of challenged cells in S phase when SET was overexpressed ( Figure 2C ).
To investigate whether the delay in S and G2 phase progression is due to a defect in DDR at collapsed forks caused by SET overexpression, we compared gH2AX in control cells and in cells overexpressing SET, treated with HU and released 0, 8, 10, 12, 16, and 24 hr after the treatment. We found that, although the amount of collapsed forks in both conditions was the same, exemplified by the levels of RPA phosphorylation at S4/S8 ( Figure 2D ), there was a notable impairment in gH2AX induction (Figures 2D and S3A) in cells overexpressing SET. These results suggest an inhibitory role of SET in DDR signaling at stalled forks.
Next, we investigated whether SET overexpression had an impact on HR at collapsed forks. To this end, we assayed the recruitment of the HR repair factors BRCA1 and RAD51. Interestingly, the number of SET-overexpressing cells that displayed BRCA1 and RAD51 foci upon HU treatment was reduced at least to 50% compared to GFP-expressing cells (Figures 3A and 3B) . Overall, these results show that overexpression of SET impedes DDR and recruitment of HR factors at collapsed forks.
To test whether a similar phenomenon was observed at endonuclease-induced DSBs in SET-overexpressing conditions, we used a cellular system in which a single DSB can be created at a specific genomic site (Lemaître et al., 2012; Soutoglou and Misteli, 2008) . In this system, expression of I-SceI induces a DSB that can be visualized by monitoring localization of GFPtagged lac repressor (GFP-lacI) and the early DDR marker gH2AX ( Figures 3C and 3D ). Remarkably, SET overexpression led to a defect in the recruitment of BRCA1 and RAD51 at the lacO/I-SceI array ( Figure 3E ). These observations were not due to chances of the cell-cycle profile, as SET overexpression had no impact on the cell cycle ( Figure S3B ). Similar results were obtained when RAD51 and BRCA1 foci were quantified in GFP and GFP-SET cells that were treated with NCS ( Figures S3C-S3E ).
We next used the lacO-lacI/I-SceI system to evaluate the impact of direct SET tethering to chromatin on the recruitment of HR proteins to DSBs. To this end, SET was fused to lacI and mCherry to generate mCherry-lacI-SET ( Figures 4A and 4B ). Stable association of SET on chromatin had a dramatic effect on BRCA1 and RAD51 loading at the breaks ( Figure 4C ). To test whether the defect in BRCA1 association with breaks in conditions that SET is overexpressed has an impact on resection of these breaks, we assessed recruitment of CtIP and phosphorylation of RPA upon tethering of SET at the lacO chromatin. Indeed, SET tethering affected the recruitment of CtIP and the phosphorylation of RPA at I-SceI breaks ( Figure 4D ). Similarly, SET tethering did not change the cell-cycle profile ( Figure S4A ).
To test whether the defect in resection and recruitment of HR factors when SET is overexpressed leads to a defect in HR, we used the DR-GFP system ( Figure S4B ; Pierce et al., 1999) . As expected, depletion of BRCA1 led to a decrease in the HR efficiency ( Figures 4E and S4C ). In accordance with the previous observations of HR factor recruitment, SET overexpression decreased significantly the efficiency of HR without altering the cell-cycle patterns, and depletion of SET had the opposite effect ( Figures 4E, S4C , and S4D).
Next we investigated whether the role of SET on HR had an impact on NHEJ. As depicted in Figure 4F , SET overexpression increased NHEJ levels. This result at the same time excluded the possibility of defective I-SceI cutting efficiency in the HR experiment due to increased chromatin compaction after SET overexpression. To study the role of SET in NHEJ, we checked the kinetics of recruitment of 53BP1 at the I-SceI breaks ( Figures  S4E-S4H) . Interestingly, although the percentage of cells that exerted 53BP1 colocalization with the lacO/I-SceI locus was not different between control cells and cells overexpressing SET at a time point when there was peak DDR, inducible expression of I-SceI demonstrated that 53BP1 was recruited earlier in cells that overexpressed SET ( Figures S4G and S4H ).
SET Interacts with KAP1 and Facilitates KAP1 and HP1 Retention to Chromatin
To investigate the mechanism of action of SET, we searched for potential interaction partners. SET immunoprecipitation followed by mass spectrometry revealed co-repressor KAP1 (KRABassociated protein-1) as an interacting partner of SET. To verify this interaction, we performed GFP-Trap immunoprecipitation experiments using the previously described U2OS GFP and GFP-SET cell lines. We observed an interaction between SET and KAP1 that did not depend on the presence of DNA damage ( Figure 5A ). Furthermore, the addition of Benzonase at the CoIP demonstrated that the interaction of SET and KAP1 is DNA independent ( Figure S5A ).
To further explore the functional significance of SET and KAP1 interaction, and to test whether KAP1 is involved in any of the phenotypes related to SET overexpression, we examined its localization in cells overexpressing SET. Immunofluorescence staining showed similar KAP1 nuclear localization in U2OS cells overexpressing GFP-SET or GFP ( Figure 5B ). On the other hand, when immunofluorescence was performed under conditions in which all soluble proteins were pre-extracted before fixation, we observed a dramatic increase of KAP1 retention to chromatin when SET was overexpressed ( Figure 5B , bottom, quantified in Figure 5C ). The enhanced retention of KAP1 to chromatin in GFP-SET cells also was observed by biochemical cell fractionation ( Figure 5D ). To further strengthen this observation, we tested the chromatin retention of exogenously expressed cherry-KAP1 in GFP and GFP-SET cells after pre-extraction. We observed that, although the levels of cherry-KAP1 in GFP and GFP-SET cells were pretty similar (Figure S5B ), the retention of cherry-KAP1 to chromatin after pre-extraction was enhanced in SET-overexpressing cells (Figures S5C and S5D) . These results point to a role of SET in KAP1 chromatin retention.
KAP1 is known to mediate gene silencing by recruiting the methyltransferase SETDB1, which specifically tri-methylates histone H3 at Lys-9 (H3K9me3) (Schultz et al., 2001 (Schultz et al., , 2002 . To examine whether KAP1 chromatin retention in SET overexpression leads to increased H3 K9 methylation, we performed immunofluorescence in U2OS GFP and GFP-SET cells after pre-extraction of soluble proteins. Following the pattern of KAP1, H3K9me3 levels were also higher in SET-overexpressing conditions ( Figure 5E , quantified in Figures 5F and S5E, right) .
KAP1-mediated gene silencing also involves the recruitment of Heterochromatin protein 1 (HP1s: HP1a, b, and g) through direct protein-protein interaction with KAP1, or through binding to H3K9me3 mark (Nielsen et al., 1999; Ryan et al., 1999) . In line with the previous observations, SET overexpression led to a higher retention of HP1s in chromatin ( Figure 5G ). This phenomenon was particularly pronounced with HP1g, which appeared globally perturbed, being more pan-nuclear than in the heterochromatic foci, and was not observed in another chromatin-bound protein like TBP ( Figures 5G and S5F ).
In line with the above observations, tethering of SET at the lacO led to the retention of KAP1 and HP1s at the locus ( Figures  6A, 6B , S6A, and S6B). Among the HP1s, the most significant effect was observed with HP1g ( Figure 6B ). Similar results were obtained when an I-SceI DSB was induced adjacent to the lacO locus. It is noteworthy that HP1g colocalization with the array exerted a 40% reduction upon induction of the I-SceI break in cells expressing the lac repressor alone ( Figure 6B) , showing that HP1g is evicted from the lacO chromatin upon DNA damage. Interestingly, upon SET tethering eviction of HP1g was not observed, suggesting that SET inhibits the eviction of HP1g and retains it stably bound to chromatin ( Figure 6B ).
Chromatin Compaction Inhibits Resection and Recruitment of HR Factors
Retention of HP1s in chromatin is likely to result in chromatin compaction. Indeed, cells overexpressing GFP-SET had smaller nuclear size compared to cells that expressed GFP (Figures S6C  and S6D ). Moreover, GFP-SET cells exerted resistance to micrococcal nuclease (Mnase) accessibility compared to GFP cells ( Figure 6C ), another indication of chromatin compaction. In agreement with this observation, detailed quantification of replication patterns in GFP and GFP-SET cells demonstrated that, although cells that overexpress SET have the same number of cells in S phase, they have a higher population of cells in late S phase than control cells, and SET-depleted cells have the reverse phenotype with less cells in late S (Figures S6E-S6H ). These observations altogether point to a role of SET in chromatin compaction.
To investigate whether the chromatin compaction mediates the SET-dependent defect in loading of HR factors in DNA lesions, we alleviated chromatin compaction using Trichostatin A (TSA) (Tó th et al., 2004) and assessed RAD51 and BRCA1 foci formation at lacO/I-SceI breaks after SET tethering. As shown in Figure 6D , TSA treatment rescued the defect on BRCA1 and RAD51 at lacO/I-SceI breaks. Furthermore, TSA treatment rescued the recruitment of CtIP and RPA phosphorylation at the lacO/I-SceI locus, suggesting that chromatin compaction impacts resection ( Figure 6E ). Similarly, TSA treatment rescued the decrease observed in gH2AX at collapsed forks upon HU treatment ( Figure 6F ).
To test whether retention of KAP1 to chromatin is sufficient to induce the effects seen by SET tethering, we fused KAP1 to mCherry-lacI and tethered it to lacO. Interestingly, KAP1 tethering to lacO resulted in impairing the recruitment of RAD51, BRCA1, and CtIP after break induction with I-SceI ( Figure S6I ), which is in total accordance with the results coming from SET tethering on the chromatin. Moreover, tethering of KAP1 on the lacO array accumulated all three HP1s on the chromatin, but HP1g seemed to be the one that was present almost 100% along with KAP1 ( Figure S6J ).
As HP1g is the most pronounced at the lacO chromatin among all HP1s when SET is tethered, we investigated whether HP1g retention could be part of the mechanism leading to the resection impairment observed in SET-overexpressing conditions. Therefore, we asked whether HP1g tethering to the lacO array by fusion with lac repressor and with GFP could recapitulate the SET-tethering phenotype ( Figures 7A and S7A-S7C ). Tethering of HP1g at the lacO array resulted in a substantial decrease in BRCA1, RAD51, CtIP, and phosphorylated RPA recruitment upon I-SceI break induction compared to the lac repressor alone ( Figures 7A and 7B ). This phenotype was specific to HP1g since it was not observed upon tethering of HP1a or b (Figures 7A  and 7B ).
To further investigate the involvement of HP1g in SETdependent functions, we assayed resection and loading of BRCA1 and RAD51 at the lacO/I-SceI break upon SET tethering in control cells and cells depleted for HP1g. Although when SET was tethered to chromatin CtIP, BRCA1, RAD51 loading, and treatment with 10 mM HU and release for the indicated time points. Photos of at least 100 cells were analyzed for each condition. SEM represents the errors from three independent experiments. (legend continued on next page) phosphorylated RPA at the lacO/I-SceI was decreased compared to cells that expressed mCherry-lacI alone, downregulation of HP1g partially rescued this defect ( Figures 7C and  S7E ). Downregulation of HP1a or b did not show any rescue and, on the contrary, affected resection and loading of HR proteins ( Figure S7F ), as shown previously (Baldeyron et al., 2011; Lee et al., 2013; Soria and Almouzni, 2013) . The depletion of HP1s by siRNA was tested by western blot ( Figure S7G ). These findings point to a role of SET in KAP1 and HP1 retention to chromatin, and, when this is exaggerated, it results in impaired HR.
Depletion of SET in conditions where HP1g was tethered to lacO chromatin did not rescue the recruitment of BRCA1 and (legend continued on next page) RAD51, suggesting that HP1g is downstream of SET and, once tethered to chromatin by other means, can exert its function ( Figure S7D) .
Finally, the tight relationship among SET, H3K9me3, and HP1g was examined by immunohistochemical and immunofluorescent means in serial sections from head and neck and colon cancers. SET had low expression in normal tissues, whereas its detection in cancerous lesions was evident (data not shown). Most importantly and in accordance with our model, the serial section analysis clearly depicted a correlation in increased levels of SET, H3K9me3, and HP1g ( Figures 7D and 7E) .
Our results altogether propose a model in which SET associates with DNA breaks to moderate DDR and DNA repair by HR in the surrounding chromatin by regulating chromatin compaction. SET binds KAP1 and its overexpression leads to amplification of its normal function due to increased retention of KAP1 and HP1s to chromatin, leading to a repressive micro-enviroment for HR as the inefficient chromatin opening can inhibit resection and recruitment of major DNA repair factors ( Figure 7F ).
DISCUSSION
SET/TAF-Ib, also known as I2PP2A and INHAT, was originally identified as a translocated gene in acute undifferentiated leukemia (Adachi et al., 1994) . It is a multi-tasking protein and it was shown to be a potent inhibitor of phosphatase 2A (PP2A) (Li et al., 1996) . It belongs to the NAP1 family of histone chaperones (Kawase et al., 1996; Muto et al., 2007) . Other studies have shown that SET/TAF-Ib binds to nucleosomal histones and inhibits histone acetylation by masking histone tails as a component of the INHAT complex (Kutney et al., 2004; Schneider et al., 2004) . Here we describe a novel function of SET in DDR and DNA repair. We have found that SET is an endogenous modulator of DDR and, when depleted, enhances DDR and survival in radiomimetic drugs. In addition, we show that SET overexpression impairs DDR and HR and reduces survival in response to damaging agents. In line with our observations, SET depletion also was found to increase gH2AX in a high-content screen for chromatin-related proteins that affect DDR upon ionizing radiation (IR) (Floyd et al., 2013) . The functions of SET in our study are independent from its role at the INHAT complex, since pp32, another component of the complex, did not exert similar functions in DDR and DNA repair as SET (data not shown).
In search of a potential mechanism of action of SET, we found that it interacts with KAP1 and mediates its retention to chromatin. Our results altogether suggest a model in which SETdependent KAP1 chromatin retention leads to the retention of its interaction partner, the methyl-transferase SETDB1, and an increase in its target histone modification ( Figures 5B-5F and S5E). Consequently, this heterochromatic mark triggers increased retention of the HP1 proteins to chromatin. In the presence of DNA damage, KAP1 and HP1s are not properly released from chromatin in SET-overexpressing cells, leading to inaccessibility of DNA repair factors and subsequent repair defect (Figure 4E) . Given that the characterization of the interaction domain(s) of SET with KAP1 was not the focus of this study, future studies are necessary to uncover how SET recruits KAP1 and if its histone chaperone activity is connected with it.
Recent studies have highlighted the importance of KAP1 phosphorylation in HP1 and CHD3 release from heterochromatin to allow chromatin relaxation and access to DNA repair factors, leading to the efficient repair of heterochromatic lesions (Ayoub et al., 2008; Bolderson et al., 2012; Garvin et al., 2013; Goodarzi et al., 2011; White et al., 2012) . For HP1b, this release was dependent on its phosphorylation by casein kinase II (Ayoub et al., 2008) . On the other hand, all three HP1 isoforms are shown to accumulate in DNA lesions through their chromoshadow domain (Luijsterburg et al., 2009; Soria and Almouzni, 2013) . These contradictory findings can be reconciled to a model in which HP1 mobilization from DSBs is followed by its accumulation at these or other sites of damage. In accordance with this bimodal behavior of HP1s, although ATM is activated to induce chromatin relaxation by KAP1 phosphorylation immediately after damage, it was shown that, in breaks in which resection had occurred, ATM activity was diminished, pointing to a need for chromatin reconstitution for late steps of HR to occur (Geuting et al., 2013) . Our results are in agreement with the necessity of open chromatin for DDR and DNA end resection.
Our results reveal distinct behavior of HP1 isoforms in response to DNA damage. First, we show that exclusively HP1g, and not a or b, is released from I-SceI-induced breaks. Moreover, persistent binding of HP1g to chromatin inhibits resection and subsequent strand invasion, exemplified by the defective recruitment of RAD51 and BRCA1 (Figures 7A and 7B) . Our observations are in line with recent data that revealed differences in how the HP1 isoforms regulate HR (Soria and Almouzni, 2013) . Although, HP1a and HP1b promote RPA phosphorylation, recruitment of RAD51, and HR stimulation, HP1g plays an inhibitory role, suggesting that its release is necessary for efficient repair by HR. Also, the effect of chromatin compaction on DNA end resection observed by SET overexpression is in keeping with recent studies, which found that HR is activated at DSBs located within actively transcribed genes that reside in euchromatin (Aymard et al., 2014; Jha and Strahl, 2014; Pai et al., 2014) .
One study described SET as a chaperone of histone H1 and demonstrated that SET is regulating the eviction of histone H1 from chromatin (Kato et al., 2011) . Moreover, knockout of some of the histone H1 isoforms leads to an increase in DDR due to chromatin decondensation (Murga et al., 2007) . Our data show that SET overexpression leads to chromatin compaction and reduced DDR that fits more with enhanced binding of H1 to chromatin than enhanced eviction. Possible explanations for this discrepancy are that prolonged overexpression of SET leads (C) MNase digestion of chromatin from U2OS GFP and GFP-SET nuclei and quantification (right) are shown. (D and E) As in (A) and (B), the lacO U2OS cells also were treated with either DMSO or TSA for 8 hr prior to fixation and cells were immunostained against RAD51, BRCA1, CtIP, and P-RPA32 S4/8. SEM represents the errors from three independent experiments. (F) Western blot analysis of whole-cell extracts of U2OS GFP and GFP-SET cells that were treated with 10 mM HU for 24 hr and released in DMSO or TSA for the indicated time points is shown.
to an imbalance of the different histone H1 isoforms, leading to complex phenotypes, or that the functions of SET on DSB repair are independent of its histone chaperone activity.
SET is highly overexpressed in various types of cancers (Adachi et al., 1994; Christensen et al., 2011; Jiang et al., 2011; Leopoldino et al., 2012; Li et al., 2012; Ouellet et al., 2006) , and in certain cases SET levels correlate with disease severity . Although, it was proposed that SET leads to tumorigenesis because it inhibits the tumor suppressor PP2A or metastasis suppressor NM23-H1 (Switzer et al., 2011) , our results suggest that defective DNA repair by HR in cells that overexpress SET also might contribute to the initiation of carcinogenesis and/or progression.
Moreover, SET has been shown to interact with the tumor suppressor p53 (Kim et al., 2012) . SET inhibits p53 acetylation thus repressing transcription of its target genes, leading to impairment of p53-dependent cell-cycle arrest and apoptosis. These results are fitting with the observation that SET is overexpressed in cancer. Although, we haven't directly tested the activation of p53 target genes in our system, the reduced cell survival upon DNA damage in SET-overexpressing cells could be attributed to impaired apoptosis and cell-cycle arrest.
Therefore, SET represents an attractive therapeutic target for cancer therapy. In keeping with this, recent studies have reported the development of peptides like COG112 (Switzer et al., 2011) that inhibit the binding of SET with PP2A or NM23-H1 and release them from the SET inhibitory effect. In addition, our results demonstrating that SET-overexpressing cells are hypersensitive to replication stress agents, such as camptothecin ( Figure 2B ), suggest that these types of agents, which are widely used in the clinic, may be exploited to target tumors expressing high levels of SET.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfections U2OS and U2OS-lacO-ISceI-Tet19 cells were cultured at 37 C in DMEM supplemented with glucose (4.5 g/l), 10% fetal calf serum, and gentamycine (40 mg/ml). U2OS GFP and U2OS GFP-SET cells were cultured as U2OS cells with the addition of 0.8 g/ml G418. FuGene 6 (Promega) and Interferin (Polyplus Transfection) were used for transient transfections of plasmids and siRNA transfections (20 nM final concentration of siRNA), respectively.
Laser Microirradiation
For 405-nm UV-laser irradiation, experiments were carried out as described by Kruhlak et al. (2006) .
ChIP
The ChIP was performed as previously ) with a few changes as described in the Supplemental Experimental Procedures.
GFP-Trap
U2OS GFP and GFP-SET cells were collected in lysis buffer (10 mM Tris/Cl [pH 7.5], 150 mM NaCl, 0.5 mM EDTA, 0.5% NP40, and protease inhibitor cocktail [Roche] ), incubated for 20 min on ice and centrifuged for another 20 min (14,000 rpm, 4 C). The supernatant was incubated with GFP-trap beads (Chromotek) for 2 hr at 4 C under rotation. Beads were washed and eluted in SDS sample buffer.
Biochemical Fractionation
Biochemical fractionation was carried out as previously described (Andegeko et al., 2001 ).
HR and NHEJ Assay DR-GFP cells (HR) and GCV6 cells (NHEJ) (Rass et al., 2009) were transfected with pcDNA-FLAG or pcDNA-FLAG-SET or the appropriate siRNAs in combination with either BFP-C1 or BFP-C1-I-SceI. Then 72 hrs after transfection, the cells were collected and fixed with 4% paraformaldehyde in PBS for 10 min at room temperature. Samples were submitted to fluorescence-activated cell sorting (FACS) analyzed by FlowJo.
MNase Assay
The assay was carried out as previously described with a few changes (Ziv et al., 2006 
